384 related articles for article (PubMed ID: 33435170)
21. Resveratrol Suppresses Cross-Talk between Colorectal Cancer Cells and Stromal Cells in Multicellular Tumor Microenvironment: A Bridge between In Vitro and In Vivo Tumor Microenvironment Study.
Buhrmann C; Shayan P; Brockmueller A; Shakibaei M
Molecules; 2020 Sep; 25(18):. PubMed ID: 32962102
[TBL] [Abstract][Full Text] [Related]
22. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
Subtil B; Cambi A; Tauriello DVF; de Vries IJM
Front Immunol; 2021; 12():724883. PubMed ID: 34691029
[TBL] [Abstract][Full Text] [Related]
23. Colorectal cancer murine models: Initiation to metastasis.
Pothuraju R; Khan I; Jain M; Bouvet M; Malafa M; Roy HK; Kumar S; Batra SK
Cancer Lett; 2024 Apr; 587():216704. PubMed ID: 38360138
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles.
Bauleth-Ramos T; Feijão T; Gonçalves A; Shahbazi MA; Liu Z; Barrias C; Oliveira MJ; Granja P; Santos HA; Sarmento B
J Control Release; 2020 Jul; 323():398-411. PubMed ID: 32320816
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in spheroid-based microfluidic models to mimic the tumour microenvironment.
Ro J; Kim J; Cho YK
Analyst; 2022 May; 147(10):2023-2034. PubMed ID: 35485712
[TBL] [Abstract][Full Text] [Related]
27. Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma.
Ramzy GM; Koessler T; Ducrey E; McKee T; Ris F; Buchs N; Rubbia-Brandt L; Dietrich PY; Nowak-Sliwinska P
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486365
[TBL] [Abstract][Full Text] [Related]
28. Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines.
Koch J; Mönch D; Maaß A; Gromoll C; Hehr T; Leibold T; Schlitt HJ; Dahlke MH; Renner P
PLoS One; 2021; 16(1):e0244513. PubMed ID: 33395433
[TBL] [Abstract][Full Text] [Related]
29. 3D modeling in cancer studies.
Atat OE; Farzaneh Z; Pourhamzeh M; Taki F; Abi-Habib R; Vosough M; El-Sibai M
Hum Cell; 2022 Jan; 35(1):23-36. PubMed ID: 34761350
[TBL] [Abstract][Full Text] [Related]
30. Recellularized Colorectal Cancer Patient-derived Scaffolds as in vitro Pre-clinical 3D Model for Drug Screening.
Sensi F; D'Angelo E; Piccoli M; Pavan P; Mastrotto F; Caliceti P; Biccari A; Corallo D; Urbani L; Fassan M; Spolverato G; Riello P; Pucciarelli S; Agostini M
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183226
[TBL] [Abstract][Full Text] [Related]
31. Advances in 3D Culture Models to Study Exosomes in Triple-Negative Breast Cancer.
Yousafzai NA; El Khalki L; Wang W; Szpendyk J; Sossey-Alaoui K
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473244
[TBL] [Abstract][Full Text] [Related]
32. Three-Dimensional Spheroids for Cancer Research.
Tutty MA; Prina-Mello A
Methods Mol Biol; 2023; 2645():65-103. PubMed ID: 37202612
[TBL] [Abstract][Full Text] [Related]
33. Involvement of parathyroid hormone-related peptide in the aggressive phenotype of colorectal cancer cells.
Novoa Díaz MB; Carriere PM; Martín MJ; Calvo N; Gentili C
World J Gastroenterol; 2021 Nov; 27(41):7025-7040. PubMed ID: 34887626
[TBL] [Abstract][Full Text] [Related]
34. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
Li J; Liu J; Xia W; Yang H; Sha W; Chen H
Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
[TBL] [Abstract][Full Text] [Related]
35. Tumor Microenvironment Shapes Colorectal Cancer Progression, Metastasis, and Treatment Responses.
Li J; Chen D; Shen M
Front Med (Lausanne); 2022; 9():869010. PubMed ID: 35402443
[TBL] [Abstract][Full Text] [Related]
36. Intestinal organoids: a model to study the role of microbiota in the colonic tumor microenvironment.
Nalluri H; Subramanian S; Staley C
Future Microbiol; 2020 Oct; 15():1583-1594. PubMed ID: 33215543
[TBL] [Abstract][Full Text] [Related]
37. Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines.
Luca AC; Mersch S; Deenen R; Schmidt S; Messner I; Schäfer KL; Baldus SE; Huckenbeck W; Piekorz RP; Knoefel WT; Krieg A; Stoecklein NH
PLoS One; 2013; 8(3):e59689. PubMed ID: 23555746
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment.
Brockmueller A; Girisa S; Kunnumakkara AB; Shakibaei M
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902421
[TBL] [Abstract][Full Text] [Related]
39. The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches.
Zafari N; Khosravi F; Rezaee Z; Esfandyari S; Bahiraei M; Bahramy A; Ferns GA; Avan A
J Clin Lab Anal; 2022 Aug; 36(8):e24585. PubMed ID: 35808903
[TBL] [Abstract][Full Text] [Related]
40. Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology.
Xie H; Appelt JW; Jenkins RW
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]